CRNX

Crinetics Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, dedicated to developing groundbreaking therapies for rare endocrine diseases and associated tumors. The company possesses a robust pipeline of innovative drug candidates, targeting significant unmet needs in the endocrine disorder market with both oral and targeted therapies. Crinetics is committed to advancing research and development efforts, positioning itself as a leader in specialized endocrine treatments, and striving to improve patient outcomes while transforming treatment paradigms in this vital healthcare sector.